Costo-Efficacia Di Cabozantinib Nel Trattamento Di Seconda Linea Del Tumore a Cellule Renali Metastatico (mRCC) in Italia
Global and Regional Health Technology Assessment - Italy
doi 10.1177/2284240318790734
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2018
Authors
Publisher
Aboutscience Srl